Grant: Discovery Grants Program - Individual
The University of British Columbia
$29,000.00
Novel Antimicrobial Host Defense Peptides: Design and Immunomodulatory Function
FY 2023-24
Summary
Antimicrobial resistance (AMR) is an increasingly important global health concern, with simple bacterial infections becoming once again prevalent and lethal. The recent SARS-CoV2 pandemic has further exacerbated resistance, because antibiotics are being heavily overprescribed to COVID-19 patients even when only small proportions display bacterial co-infection. Host defense peptides (HDPs) are a viable solution against resistant bacteria due to their diverse mechanisms of action, such as direct bacterial killing as well as immunomodulatory properties. Despite their promise, HDPs are however seldom used in a clinical setting because their therapeutic efficacy is limited by rapid degradation, systemic toxicity, and low bioavailability. In the last 6 years, the Straus group has done extensive work to improve the applicability of HDPs. New peptides, which are highly active against resistant bacteria, were generated and their mechanism of action was elucidated. Moreover, formulation and conjugation strategies that mitigate the limitations of HDPs were developed. The resulting approaches show tremendous promise. However, in order to further broaden the usage of HDPs, three important areas require further in-depth study: 1) understanding how immunomodulatory HDPs (iHDPs) function at a molecular level; 2) tailoring delivery strategies for iHDPs by understanding how conjugation impacts the mechanism of action; and 3) developing approaches to repurpose commonly used antibiotics in order to have ready solutions to the AMR problem. Specifically, this proposal outlines objectives that will enable a team of diverse HQP to develop as independent researchers, with strong training in interdisciplinary, collaborative research and thorough knowledge of biophysical techniques (e.g. NMR, ITC, CD, etc.). Trainees will benefit from a work environment where equity, diversity and inclusion are core values: most trainees in the Straus group are women and from visible minorities. To understand the mechanism of action of iHDPs (aim 1), two PhD students will determine how these peptides affect macrophage differentiation by studying HDP/macrophage interactions, a new area of research. They will also investigate how amino acid composition modulates immunomodulatory activity. In terms of conjugation (2), two PhD students will further fine-tune current approaches and adapt them to iHDPs, as well as determine (e.g. using whole bacterial cell NMR) how the mode of action of the polymer-HDP conjugate differs from the HDP alone. Finally, using our knowledge on conjugation, a PhD student will devise methods to create new antibiotics (3) consisting of commonly used molecules plus HDPs. In this way, the benefit of current antibiotics (high activity, low toxicity) can be harnessed, while minimizing resistance effects. Overall, the proposed program will ensure that novel fundamental knowledge required to address the AMR problem is obtained, so that tangible solutions can be developed.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2022-03089
Name nom
Straus, Suzana
Department département
Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3403
Research subject group en
Physical chemistry
Research subject group fr
Spectroscopy
Research subject en
Chimie physique
Research subject fr
Spectroscopie
Application title
Novel Antimicrobial Host Defense Peptides: Design and Immunomodulatory Function
Keyword
antibiotics; antimicrobial host defense peptides; bioconjugates; biophysical chemistry; hyperbranched polyglycerol; immunomodulatory activity; mechanism of action; multi-drug resistant bacteria; nuclear magnetic resonance; polyethylene glycol
Application summary
Antimicrobial resistance (AMR) is an increasingly important global health concern, with simple bacterial infections becoming once again prevalent and lethal. The recent SARS-CoV2 pandemic has further exacerbated resistance, because antibiotics are being heavily overprescribed to COVID-19 patients even when only small proportions display bacterial co-infection. Host defense peptides (HDPs) are a viable solution against resistant bacteria due to their diverse mechanisms of action, such as direct bacterial killing as well as immunomodulatory properties. Despite their promise, HDPs are however seldom used in a clinical setting because their therapeutic efficacy is limited by rapid degradation, systemic toxicity, and low bioavailability. In the last 6 years, the Straus group has done extensive work to improve the applicability of HDPs. New peptides, which are highly active against resistant bacteria, were generated and their mechanism of action was elucidated. Moreover, formulation and conjugation strategies that mitigate the limitations of HDPs were developed. The resulting approaches show tremendous promise. However, in order to further broaden the usage of HDPs, three important areas require further in-depth study: 1) understanding how immunomodulatory HDPs (iHDPs) function at a molecular level; 2) tailoring delivery strategies for iHDPs by understanding how conjugation impacts the mechanism of action; and 3) developing approaches to repurpose commonly used antibiotics in order to have ready solutions to the AMR problem. Specifically, this proposal outlines objectives that will enable a team of diverse HQP to develop as independent researchers, with strong training in interdisciplinary, collaborative research and thorough knowledge of biophysical techniques (e.g. NMR, ITC, CD, etc.). Trainees will benefit from a work environment where equity, diversity and inclusion are core values: most trainees in the Straus group are women and from visible minorities. To understand the mechanism of action of iHDPs (aim 1), two PhD students will determine how these peptides affect macrophage differentiation by studying HDP/macrophage interactions, a new area of research. They will also investigate how amino acid composition modulates immunomodulatory activity. In terms of conjugation (2), two PhD students will further fine-tune current approaches and adapt them to iHDPs, as well as determine (e.g. using whole bacterial cell NMR) how the mode of action of the polymer-HDP conjugate differs from the HDP alone. Finally, using our knowledge on conjugation, a PhD student will devise methods to create new antibiotics (3) consisting of commonly used molecules plus HDPs. In this way, the benefit of current antibiotics (high activity, low toxicity) can be harnessed, while minimizing resistance effects. Overall, the proposed program will ensure that novel fundamental knowledge required to address the AMR problem is obtained, so that tangible solutions can be developed.